F18.91 Billable / specific Inhalant use, unspecified, in remission
ICD-10-CM F18.91 identifies “Inhalant use, unspecified, in remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 5: Mental, Behavioral and Neurodevelopmental disorders
Code-level instructions
No additional notes.
Inherited instructions
Chapters 5 · Mental, Behavioral and Neurodevelopmental disorders (F01-F99)
Includes1
disorders of psychological development
Excludes 21
symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)
F18 · Inhalant related disorders
Includes1
volatile solvents
F18.9 · Inhalant use, unspecified
Official index references
Official index references (1)
Use(of) (1)
- Use(of) › inhalants › in remissionDisease index
Official conversion history
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Previous assignment: F18.90
History
Code history
Latest recorded change · FY2023
Effective from
- Added
Inhalant use, unspecified, in remission
Billable diagnosis code
CDC/NCHS · FY2023All editions (9)
| All editions | Effective from | Code history |
|---|---|---|
| FY2023 | 2022-10-01 | Added |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.